NCT07136714View on ClinicalTrials.gov

Does Semaglutide Improve Depressive Symptoms in Patients With Major Depressive Disorder and Overweight or Obesity

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

116

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

September 30, 2027

Study Completion Date

September 30, 2027

Conditions
Major Depressive Disorder
Interventions
DRUG

Semaglutide Injectable Product

Semaglutide (Wegovy) once-weekly injection s.c

DRUG

Placebo

Placebo (BD Posiflush) once-weekly injection s.c

Trial Locations (1)

3400

Mental Health Centre North Zealand, Hillerød

All Listed Sponsors
lead

Maj Vinberg

OTHER